Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 485

1.

Metabolic regulation of activins in healthy individuals and in obese patients undergoing bariatric surgery.

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Tsilingiris D, Alexandrou A, Mantzoros CS.

Diabetes Metab Res Rev. 2020 Feb 5:e3297. doi: 10.1002/dmrr.3297. [Epub ahead of print]

PMID:
32026536
2.

Sex specific effect of ATPase inhibitory factor 1 on body weight: studies in high fat diet induced obese mice and genetic association studies in humans.

Kwak SY, Chung I, Kang J, Perakakis N, Yoo EH, Lee J, Jung HT, Mun BR, Choi WS, Kim OY, Kim S, Kim EK, Oh H, Mantzoros CS, Chung JH, Kim HS, Shin MJ.

Metabolism. 2020 Jan 30;105:154171. doi: 10.1016/j.metabol.2020.154171. [Epub ahead of print]

PMID:
32006557
3.

Variants in ADIPOQ gene are linked to adiponectin levels and lung function in young males independent of obesity.

Christodoulou A, Ierodiakonou D, Awofala AA, Petrou M, Kales SN, Christiani DC, Mantzoros CS, Christophi CA.

PLoS One. 2020 Jan 24;15(1):e0225662. doi: 10.1371/journal.pone.0225662. eCollection 2020.

4.

Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns.

Polyzos SA, Kountouras J, Mantzoros CS.

Metabolism. 2020 Jan 11;104:154144. doi: 10.1016/j.metabol.2020.154144. [Epub ahead of print] No abstract available.

PMID:
31930974
5.

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials.

Mantovani A, Byrne CD, Scorletti E, Mantzoros CS, Targher G.

Diabetes Metab. 2020 Jan 7. pii: S1262-3636(20)30002-1. doi: 10.1016/j.diabet.2019.12.007. [Epub ahead of print]

PMID:
31923578
6.

Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale.

Galindo-Mendez B, Trevino JA, McGlinchey R, Fortier C, Lioutas V, Novak P, Mantzoros CS, Ngo L, Novak V.

Contemp Clin Trials. 2020 Jan 7;89:105934. doi: 10.1016/j.cct.2020.105934. [Epub ahead of print]

PMID:
31923471
7.

Adiponectin and leptin in the diagnosis and therapy of NAFLD.

Boutari C, Mantzoros CS.

Metabolism. 2020 Feb;103:154028. doi: 10.1016/j.metabol.2019.154028. Epub 2019 Nov 27. No abstract available.

PMID:
31785257
8.

Metabolism updates: new directions, techniques, and exciting research that is broadening the horizons.

Boutari C, Bouzoni E, Joshi A, Stefanakis K, Farr OM, Mantzoros CS.

Metabolism. 2020 Jan;102:154009. doi: 10.1016/j.metabol.2019.154009. Epub 2019 Nov 9. No abstract available.

PMID:
31715175
9.

Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study.

Perakakis N, Polyzos SA, Yazdani A, Sala-Vila A, Kountouras J, Anastasilakis AD, Mantzoros CS.

Metabolism. 2019 Dec;101:154005. doi: 10.1016/j.metabol.2019.154005. Epub 2019 Nov 9.

PMID:
31711876
10.

Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS.

J Clin Endocrinol Metab. 2020 Mar 1;105(3). pii: dgz172. doi: 10.1210/clinem/dgz172.

PMID:
31690932
11.

Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials.

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Pilitsi E, Upadhyay J, Alexandrou A, Mantzoros CS.

Metabolism. 2019 Dec;101:153997. doi: 10.1016/j.metabol.2019.153997. Epub 2019 Oct 28.

PMID:
31672446
13.

ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways.

Lee HJ, Moon J, Chung I, Chung JH, Park C, Lee JO, Han JA, Kang MJ, Yoo EH, Kwak SY, Jo G, Park W, Park J, Kim KM, Lim S, Ngoei KRW, Ling NXY, Oakhill JS, Galic S, Murray-Segal L, Kemp BE, Mantzoros CS, Krauss RM, Shin MJ, Kim HS.

FASEB J. 2019 Dec;33(12):14825-14840. doi: 10.1096/fj.201901440RR. Epub 2019 Oct 31.

PMID:
31670977
14.

Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?

Kokkinos A, Tsilingiris D, le Roux CW, Rubino F, Mantzoros CS.

Metabolism. 2019 Nov;100:153960. doi: 10.1016/j.metabol.2019.153960. Epub 2019 Aug 11.

PMID:
31412266
15.

Old and new tools to study human brain physiology: Current state, future directions and implications for metabolic regulation.

Farr OM, Mantzoros CS.

Metabolism. 2019 Oct;99:iii-viii. doi: 10.1016/j.metabol.2019.153957. Epub 2019 Aug 7. No abstract available.

PMID:
31400385
16.

Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies.

Farr OM, Upadhyay J, Rutagengwa C, DiPrisco B, Ranta Z, Adra A, Bapatla N, Douglas VP, Douglas KAA, Nolen-Doerr E, Mathew H, Mantzoros CS.

Diabetes Obes Metab. 2019 Nov;21(11):2459-2464. doi: 10.1111/dom.13827. Epub 2019 Aug 8.

PMID:
31282006
17.

Of mice and men: incretin actions in the central nervous system.

Farr OM, Pilitsi E, Mantzoros CS.

Metabolism. 2019 Sep;98:121-135. doi: 10.1016/j.metabol.2019.05.013. Epub 2019 Jun 4. Review.

PMID:
31173757
18.

Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?

Polyzos SA, Kountouras J, Mantzoros CS.

Metabolism. 2019 Jul;96:iii-v. doi: 10.1016/j.metabol.2019.05.006. Epub 2019 May 20. No abstract available.

PMID:
31121179
20.

Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross-over, randomized, double-blind, controlled inpatient physiology study.

Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Klapa MI, Candela M, Rampelli S, Lehoux S, Lázaro I, Sala-Vila A, Brigidi P, Cummings RD, Mantzoros CS.

Diabetes Obes Metab. 2019 Sep;21(9):2086-2095. doi: 10.1111/dom.13773. Epub 2019 Jul 2.

PMID:
31087608
21.

Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.

Polyzos SA, Perakakis N, Mantzoros CS.

Metabolism. 2019 Jul;96:66-82. doi: 10.1016/j.metabol.2019.05.001. Epub 2019 May 6. Review.

PMID:
31071311
22.

Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.

Athyros VG, Polyzos SA, Kountouras J, Katsiki N, Anagnostis P, Doumas M, Mantzoros CS.

Curr Vasc Pharmacol. 2020;18(2):172-181. doi: 10.2174/1570161117666190405164313.

PMID:
30961499
23.

Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?

Boutari C, Polyzos SA, Mantzoros CS.

Metabolism. 2019 Jul;96:vi-xi. doi: 10.1016/j.metabol.2019.03.007. Epub 2019 Mar 22. No abstract available.

PMID:
30910448
24.

Beyond glycemic control: New guidance on cardio-renal protection.

Anastasilakis AD, Sternthal E, Mantzoros CS.

Metabolism. 2019 Oct;99:113-115. doi: 10.1016/j.metabol.2019.02.004. Epub 2019 Feb 22. No abstract available.

PMID:
30797784
25.

Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trial.

Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Mathew H, Paschou SA, Perakakis N, Koniaris A, Kelesidis T, Mantzoros CS.

Diabetes Obes Metab. 2019 Jun;21(6):1487-1492. doi: 10.1111/dom.13655. Epub 2019 Mar 18.

PMID:
30724455
26.

Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?

Anastasilakis AD, Polyzos SA, Makras P, Douni E, Mantzoros CS.

Metabolism. 2019 Apr;93:100-102. doi: 10.1016/j.metabol.2019.01.013. Epub 2019 Jan 25. No abstract available.

PMID:
30690037
27.

Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis.

Theocharidou E, Giouleme O, Anastasiadis S, Markopoulou A, Pagourelias E, Vassiliadis T, Fotoglidis A, Agorastou P, Slavakis A, Balaska A, Kouskoura MG, Gossios TD, Karagiannis A, Mantzoros CS.

Dig Dis Sci. 2019 Jun;64(6):1686-1694. doi: 10.1007/s10620-019-5460-x. Epub 2019 Jan 19.

PMID:
30659471
28.

Obesity: seize the day, fight the fat.

Polyzos SA, Mantzoros CS.

Metabolism. 2019 Mar;92:1-5. doi: 10.1016/j.metabol.2018.12.011. Epub 2019 Jan 6. No abstract available.

PMID:
30625300
29.

Research developments in metabolism 2018.

Peradze N, Farr OM, Mantzoros CS.

Metabolism. 2019 Feb;91:70-79. doi: 10.1016/j.metabol.2018.11.011. Epub 2018 Nov 29. Review. No abstract available.

PMID:
30503805
30.

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.

Polyzos SA, Kountouras J, Mantzoros CS.

Metabolism. 2019 Mar;92:82-97. doi: 10.1016/j.metabol.2018.11.014. Epub 2018 Nov 29. Review.

PMID:
30502373
31.

Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls.

Anastasilakis AD, Koulaxis D, Upadhyay J, Pagkalidou E, Kefala N, Perakakis N, Polyzos SA, Economou F, Mantzoros CS.

Horm Metab Res. 2019 Feb;51(2):112-119. doi: 10.1055/a-0794-6163. Epub 2018 Nov 29.

PMID:
30497090
32.

GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans.

Papathanasiou AE, Nolen-Doerr E, Farr OM, Mantzoros CS.

Eur J Endocrinol. 2019 Feb 1;180(2):R59-R71. doi: 10.1530/EJE-18-0847. Review.

33.

Could the endocrine disruptor bisphenol-A be implicated in the pathogenesis of oral and oropharyngeal cancer? Metabolic considerations and future directions.

Emfietzoglou R, Spyrou N, Mantzoros CS, Dalamaga M.

Metabolism. 2019 Feb;91:61-69. doi: 10.1016/j.metabol.2018.11.007. Epub 2018 Nov 17. Review.

PMID:
30458176
34.

Obesity and cancer risk: Emerging biological mechanisms and perspectives.

Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M.

Metabolism. 2019 Mar;92:121-135. doi: 10.1016/j.metabol.2018.11.001. Epub 2018 Nov 13. Review.

PMID:
30445141
35.

Follistatins in glucose regulation in healthy and obese individuals.

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Tsilingiris D, Alexandrou A, Mantzoros CS.

Diabetes Obes Metab. 2019 Mar;21(3):683-690. doi: 10.1111/dom.13572. Epub 2018 Dec 3.

PMID:
30393997
36.

Pharmacotherapy of obesity: Available medications and drugs under investigation.

Pilitsi E, Farr OM, Polyzos SA, Perakakis N, Nolen-Doerr E, Papathanasiou AE, Mantzoros CS.

Metabolism. 2019 Mar;92:170-192. doi: 10.1016/j.metabol.2018.10.010. Epub 2018 Nov 1. Review.

PMID:
30391259
37.

Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study.

Panagiotou G, Papakonstantinou E, Vagionas A, Polyzos SA, Mantzoros CS.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):349-358. doi: 10.1210/jc.2018-01581.

PMID:
30388235
38.

Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cells.

Päth G, Perakakis N, Mantzoros CS, Seufert J.

Metabolism. 2019 Jan;90:1-15. doi: 10.1016/j.metabol.2018.10.005. Epub 2018 Oct 18. Review.

PMID:
30342065
39.

Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice.

Görgülü K, Diakopoulos KN, Ai J, Schoeps B, Kabacaoglu D, Karpathaki AF, Ciecielski KJ, Kaya-Aksoy E, Ruess DA, Berninger A, Kowalska M, Stevanovic M, Wörmann SM, Wartmann T, Zhao Y, Halangk W, Voronina S, Tepikin A, Schlitter AM, Steiger K, Artati A, Adamski J, Aichler M, Walch A, Jastroch M, Hartleben G, Mantzoros CS, Weichert W, Schmid RM, Herzig S, Krüger A, Sainz B Jr, Lesina M, Algül H.

Gastroenterology. 2019 Jan;156(1):203-217.e20. doi: 10.1053/j.gastro.2018.09.053. Epub 2018 Oct 6.

PMID:
30296435
40.

Quantifying Platelet Margination in Diabetic Blood Flow.

Chang HY, Yazdani A, Li X, Douglas KAA, Mantzoros CS, Karniadakis GE.

Biophys J. 2018 Oct 2;115(7):1371-1382. doi: 10.1016/j.bpj.2018.08.031. Epub 2018 Aug 30.

41.

Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies.

Spyrou N, Avgerinos KI, Mantzoros CS, Dalamaga M.

Curr Obes Rep. 2018 Dec;7(4):260-275. doi: 10.1007/s13679-018-0318-7. Review.

PMID:
30145771
42.

Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise.

Perakakis N, Mougios V, Fatouros I, Siopi A, Draganidis D, Peradze N, Ghaly W, Mantzoros CS.

J Clin Endocrinol Metab. 2018 Oct 1;103(10):3890-3899. doi: 10.1210/jc.2018-01056.

43.

Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Mantovani A, Nascimbeni F, Lonardo A, Zoppini G, Bonora E, Mantzoros CS, Targher G.

Thyroid. 2018 Oct;28(10):1270-1284. doi: 10.1089/thy.2018.0257. Epub 2018 Aug 30.

PMID:
30084737
44.

Lessons and Challenges from a 6-Month Randomized Pilot Study of Daily Ethanol Consumption: Research Methodology and Study Design.

Mukamal KJ, Na B, Mu L, Mantzoros CS, Manning WJ, Mittleman MA.

Curr Dev Nutr. 2017 Jun 15;1(7):e000505. doi: 10.3945/cdn.117.000505. eCollection 2017 Jul.

45.

Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis.

Kountouras J, Polyzos SA, Doulberis M, Zeglinas C, Artemaki F, Vardaka E, Deretzi G, Giartza-Taxidou E, Tzivras D, Vlachaki E, Kazakos E, Katsinelos P, Mantzoros CS.

Metabolism. 2018 Oct;87:18-24. doi: 10.1016/j.metabol.2018.06.008. Epub 2018 Jun 21. Review.

PMID:
29936174
47.

Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function.

Perakakis N, Upadhyay J, Ghaly W, Chen J, Chrysafi P, Anastasilakis AD, Mantzoros CS.

Metabolism. 2018 Aug;85:240-249. doi: 10.1016/j.metabol.2018.05.003. Epub 2018 May 9.

48.

Advances at the intersection of sleep and metabolism research.

Farr OM, Mantzoros CS.

Metabolism. 2018 Jul;84:1-2. doi: 10.1016/j.metabol.2018.03.026. Epub 2018 Apr 7. No abstract available.

PMID:
29634954
49.

Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.

Boutari C, Perakakis N, Mantzoros CS.

Endocrinol Metab (Seoul). 2018 Mar;33(1):33-43. doi: 10.3803/EnM.2018.33.1.33. Review.

50.

Reproductive Endocrinology: Novel Insights into Pathophysiology and Clinical Management.

Goulis DG, Mantzoros CS.

Metabolism. 2018 Sep;86:1-2. doi: 10.1016/j.metabol.2018.03.015. Epub 2018 Mar 23. No abstract available.

PMID:
29580873

Supplemental Content

Loading ...
Support Center